The latest data from the AREST study, presented at the 2026 ASCO Annual Meeting, demonstrate that adjuvant radiation therapy following curative surgery for early-stage oral squamous cell carcinoma significantly improves disease-free survival. This underscores the importance of risk-adapted treatment planning for oral cavity tumors.
Autoren
- Dr. oec. Odile Schwarz-Herion
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
- adjuvant radiation therapy following curative surgery
- ASCO Annual Meeting 2026
- Checkpoint Inhibitors / PD-1/PD-L1
- CT/MRI and PET/CT
- Extranodal spread (ENE)
- FDG-PET
- Genomic-Adjusted Radiation Dose (GARD)
- Intensity-modulated radiation therapy (IMRT)
- multimodal therapy
- personalized treatment planning
- Pre-treatment risk stratification
- Radiotherapy / Radiation Therapy
- Squamous Cell Carcinoma of the Oropharynx (OPSCC)
- Surgical resection
- Transoral Robotic Surgery (TORS)
You May Also Like
- PMR and LVV: Current EULAR Recommendations
Polymyalgia rheumatica, giant cell arteritis, and Takayasu arteritis
- Psychedelic-assisted therapy
Current status of PAT
- First-line treatment for T2D
SGLT2i, metformin, or both?
- Biophilic Design of Work Environments
Effects on Health, Well-Being, and Productivity
- From symptom to diagnosis
Intrapelvic mass with an ambiguous differential diagnosis
- Endocrinology: APECED-Associated Hypoparathyroidism
A parathyroid hormone analog corrected serum calcium levels
- Transient ischemic attack
Comprehensive diagnostic testing can reduce the risk of stroke
- Malignant Tumors of the Clavicle